COVID-19 Yorkshire Rehabilitation Scale

A digital assessment and monitoring tool to help manage individuals with Long COVID. Free to purchase for all NHS organisations.

For more information contact: c19-yrs@elaros.com

Find out how the C19-YRS can support your organisation today

C19-YRS is an outcome measure used to screen for common persistent symptoms identified in patients after contracting COVID-19, also known as ‘long COVID’ or ‘post-COVID syndrome’. The original clinically validated tool has been developed by clinical academics at The University of Leeds following research from over 4000 patients and has been recommended for routine use by NHS England. The tool has since been updated by the clinical team and developed into a digital app by UK-based digital health company, ELAROS, to support healthcare organisations by enhancing their service delivery and providing anonymised data to The University of Leeds to further validate the scale and develop a robust psychometric measure of the condition. More details of the benefits offered by C19-YRS can be viewed through the product brochure accessible here.

Created by clinical academics

C19-YRS is a clinically relevant outcome tool developed at the University of Leeds to assess persistent COVID-19 symptoms. The tool has been adopted by NHS Trusts across the UK.

Developed with NHS Trusts

Developed with support from Leeds Teaching Hospitals and Leeds Community Healthcare NHS Trusts.

Enhanced by UK industry experts

Digitally enhanced by ELAROS 24/7 Ltd, building on their established CE-marked medical device, the Digital Bladder Diary platform. This project has been supported by Innovate UK.

Recommended by NHS England

NHS England has suggested routine use of C19-YRS at first assessment, 6 weeks and 6 months to monitor Long COVID. The tool has also been recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19.

Our Supporters

The C19-YRS has been developed by UK-based digital health company, ELAROS 24/7 Ltd, working closely with clinical researchers at The University, who provided the initial funding and developed the original self-report and with its third party strategic partner software development company, Pipe & Piper in order to rapidly develop the platform to a high level, safe and secure standard. The scale was developed by clinicians at Leeds Teaching Hospitals Trust, Leeds Community Healthcare NHS Trust, and Airedale and Hull NHS Trusts.

It has been recommended for routine use by NHS England, recognised by NICE, published in the ACNR and endorsed by the British Society for Rehabilitation Medicine.

Benefits

For clinicians

  • Multiple patients managed in one place
  • Helps capture symptoms and guide rehabilitation interventions for patients
  • Digitally enhanced integrated care
  • Clear clinical audit trail
  • Powerful reporting and research tools
  • Long term capture and analysis
  • Regularly updated with world-leading long COVID researchers

For patients

  • More reliable than a paper diary
  • Automated data capture and assessment
  • Completed anywhere, any time
  • Digitally enhanced personalised care
  • Completed alone, together with a carer or a HCP via telephone
  • More informed rehabilitation interventions, potentially leading to better patient outcomes
  • Sustainable remote patient monitoring
  • Access to regular updates from world leading researchers

For research

  • Access to anonymised data of consenting patients
  • Extensive data collection from across the UK
  • Scientific analysis by The University of Leeds
  • Advanced vital research on post-COVID syndrome
  • Development of a robust psychometric assessment of long COVID